NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 7, 2025 Bullish $21.28 X 0
Feb 21, 2025 $30.73 -2.83% $34.07 X 90.21% 0
Feb 21, 2025 $31.07 -1.77% $34.07 X 91.20% 0
Feb 21, 2025 Bullish $34.07 V 1
Feb 20, 2025 $31.39 -2.79% $31.63 V 99.24% 3
Feb 20, 2025 $31.73 -1.75% $31.63 V 99.69% 5
Feb 20, 2025 Bullish $31.63 V 0
Jan 22, 2025 $33.92 +3.18% $34.05 V 99.60% 5
Jan 22, 2025 $33.52 +1.99% $34.05 V 98.45% 1
Jan 22, 2025 $32.65 +0.00% $34.05 X 95.89% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE